Cantor Fitzgerald Cuts Price Target on Immunogen (IMGN) Following Program Adjustments
Tweet Send to a Friend
Cantor Fitzgerald maintained a Hold rating on Immunogen Inc. (NASDAQ: IMGN), and cut the price target to $19.00 (from $21.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE